(Q40923533)

24 September 2017

title

Mechanism of captopril toxicity to a human mammary ductal carcinoma cell line in the presence of copper (English)

1 reference

24 September 2017

1 reference

Small W Jr

1

1 reference

24 September 2017

Molteni A

2

1 reference

24 September 2017

Kim YT

3

1 reference

24 September 2017

Taylor JM

4

1 reference

24 September 2017

Ts'ao CH

5

1 reference

24 September 2017

Ward WF

6

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 June 1999

1 reference

Breast Cancer Research and Treatment

24 September 2017

published in

1 reference

24 September 2017

volume

55

1 reference

24 September 2017

issue

3

1 reference

24 September 2017

page(s)

223-229

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1006233521325

24 September 2017

exact match

0 references

cites work

Captopril: pharmacology, metabolism and disposition

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006233521325

The expanding role of angiotensin converting enzyme inhibitors in the management of hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006233521325

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006233521325

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006233521325

Influence of angiotensin converting enzyme inhibitor (captopril) on kidney epithelial cells in vitro: studies on potassium (86Rb) influx and cellular proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006233521325

Captopril inhibits proliferation of human lung fibroblasts in culture: a potential antifibrotic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006233521325

Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006233521325

Copper chelates of antirheumatic and anti-inflammatory agents: their superoxide dismutase-like activity and stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006233521325

Effects of in vitro addition of captopril on copper-induced low density lipoprotein oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006233521325

Effect of captopril, enalaprilat and mercaptopropionyl glycine (MPG) on the oxidative activity of human isolated neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006233521325

Captopril: a free radical scavenger

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006233521325

Protective effects of sulfhydryl-containing angiotensin converting enzyme inhibitors against free radical injury in endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006233521325

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006233521325

7 January 2021

Angiotensin-converting enzyme inhibition reduces neuroblastoma cell growth rate

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006233521325

7 January 2021

Inhibitors of angiotensin-converting enzyme modulate mitosis and gene expression in pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006233521325

7 January 2021

Captopril modulates hormone receptor concentration and inhibits proliferation of human mammary ductal carcinoma cells in culture

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006233521325

7 January 2021

Superoxide scavenging by thiol/copper complex of captopril--an EPR spectroscopy study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006233521325

7 January 2021

Superoxide dismutase activity of the captopril-iron complex

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006233521325

7 January 2021

Low density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: a possible role for angiotensin II

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006233521325

7 January 2021

The effect of captopril on the oxidation of plasma lipoproteins

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006233521325

7 January 2021

Superoxide dismutase and glutathione peroxidase activities are increased by enalapril and captopril in mouse liver

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006233521325

7 January 2021

Lipoprotein(a) and oxygen free radicals in survivors of acute myocardial infarction: effects of captopril

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006233521325

7 January 2021

The prooxidant properties of captopril

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006233521325

7 January 2021

Direct scavenging of free radicals by captopril, an angiotensin converting enzyme inhibitor

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006233521325

7 January 2021

Evaluation of the ability of the angiotensin-converting enzyme inhibitor captopril to scavenge reactive oxygen species

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006233521325

7 January 2021

Identifiers

DOI

10.1023/A:1006233521325

1 reference

Dimensions Publication ID

24 September 2017

1044381657

0 references

1 reference